Skip to main navigation Skip to search Skip to main content

Enhancement of antisense oligonucleotide-mediated exon skipping as a therapy for Duchenne muscular dystrophy

Project: Research

Project Details

StatusFinished
Effective start/end date6/02/17 → 5/02/20

Funding

  • UCB Biopharma SPRL: £55,500.00